Giving up smoking just isn’t straightforward since a smoker suffers from a physical and also a psychological addiction to nicotine. Most smokers have tried on and off to stop after which gone back to smoking. Never be afraid to ask for help to quit smoking. There are lots of effective ways to help you stop which incorporate the patch, gum, cold turkey, therapy and medication. More method has been created each day to help smokers kick the habit.
Recently, researchers from Weill Cornell Medical College have found a new method to cure the cigarette addiction than ever before. They claim that an injection of genes can develop antibodies against nicotine and might help individuals stop smoking. The method is still in its early stage but so far the researchers claim that they are on the right track to treating nicotine addiction. The research, published in the journal Science Translational Medicine describes that a single dose of the novel vaccine protects mice against a life-long addiction against nicotine.
The vaccine uses the animal’s liver as a production site to consistently produce antibodies that instantly gobble up nicotine the moment it enters the bloodstream, and for this reason prevents the chemical from reaching the brain and heart. Leading researcher, Dr. Ronald G. Crystal, chairman and professor of Genetic Medicine at Weill Cornell Medical College explains:
“As far as we can see, the best way to treat chronic nicotine addiction from smoking is to have these Pacman-like antibodies on patrol, clearing the blood as needed before nicotine can have any biological effect.”
The doctor says that if the vaccine proves definitely secure, it may be possible to prevent individuals who never smoked from being addicted to nicotine, in the very same way as vaccinations are given to stay clear of many illness-producing infections. He remarks: “Just as parents decide to supply their kids an HPV vaccine, they may possibly choose to utilize a nicotine vaccine. But that is only theoretically an alternative at this point. We would naturally have to weight advantage versus risk, and it would take years of studies to ascertain such a threshold.”